FundedIQ
Biotechnology

ShouTi: Funding, Investors & Team (Oct 2026)

ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.

shoutipharma.com LinkedIn South San Francisco, United States 11-50 employees
Biotechnology Health Care Medical Pharmaceutical Product Research
Total raised
$33.0M
Rounds
1
Latest
Series B
Aug 2022

ShouTi has raised $33.0M across 1 funding round on record, the most recent a Series B of $33.0M announced in Aug 2022.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

ShouTi Company Profile and Key Stats

Total funding raised
$33.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$33.0M in Aug 2022
Employees
11-50
reported band
Headquarters
South San Francisco, United States

Latest funding round on record: Aug 2022.

ShouTi Funding Rounds

Date
Round
Amount
Series B
$33.0M

ShouTi Founders and Leadership Team

Name
Role
Contact
Raymond Stevens
CEO
Locked

Contact details for the ShouTi team: 1 of 1 has an email address on file.

Start 14-day free trial →

ShouTi Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
4,401
$31M

ShouTi's latest round of $33.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like ShouTi in Biotechnology and South San Francisco

Companies Similar to ShouTi

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

ShouTi Funding FAQs

What does ShouTi do?

ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.

How much funding has ShouTi raised?

ShouTi has raised $33.0M across 1 round on record. The most recent is a Series B of $33.0M announced in Aug 2022.

When did ShouTi last raise funding?

ShouTi's most recent funding round on record is a Series B of $33.0M, announced in Aug 2022.

Who is the CEO of ShouTi?

Raymond Stevens is listed as CEO at ShouTi.

Where is ShouTi headquartered?

ShouTi is based in South San Francisco, California, United States.

How many employees does ShouTi have?

ShouTi is in the 11-50 employee band.

How does ShouTi's funding compare to other Biotechnology startups?

ShouTi's latest round of $33.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's ShouTi Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ShouTi is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.